Sep 9, 2026 07:30AM
Aug 13, 2026 07:30AM
Jul 14, 2026 06:55AM
May 26, 2026 07:15AM
May 26, 2026 07:15AM
May 21, 2026 11:27PM
May 21, 2026 11:27PM NervGen Announces Pricing of US$60.0 Million Public Offering of Securities
May 21, 2026 04:01PM
May 21, 2026 04:01PM
May 18, 2026 07:15AM
Apr 27, 2026 07:30AM
Apr 27, 2026 07:30AM
Apr 13, 2026 07:45AM
Apr 13, 2026 07:45AM NervGen Pharma to Participate in the H.C. Wainwright "HCW@Home" Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference
Apr 7, 2026 12:26PM
Apr 7, 2026 07:30AM
Apr 7, 2026 07:30AM
Apr 7, 2026 07:30AM
Mar 31, 2026 07:45AM
Mar 12, 2026 04:15PM
Mar 12, 2026 04:15PM NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange
Mar 4, 2026 07:31AM
Mar 4, 2026 07:30AM
Feb 18, 2026 07:30AM
Feb 12, 2026 04:15PM
Feb 12, 2026 04:15PM
Feb 11, 2026 07:00AM
Feb 9, 2026 07:00AM NervGen appoints Adam Rogers as permanent CEO
Feb 9, 2026 07:00AM
Jan 20, 2026 07:00AM
Jan 8, 2026 06:30AM
Mar 25, 2025 08:30AM
Jul 28, 2022 10:38AM
Jan 10, 2022 07:30AM
Jul 9, 2019 10:52AM NervGen Pharma To Webcast At VirtualInvestorConferences.com July 11th
Jun 10, 2019 07:00AM
Jan 6, 2017 04:05PM

331,842 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All